نتایج جستجو برای: anti angiogenic aktmtorp70s6k mechanism

تعداد نتایج: 912135  

2015
WEIWEI CAI YUE LI QINGQING YI FENGSHAN XIE BIN DU LEI FENG LIYING QIU

Dried stem bark from Albizia julibrissin (AJ) is a highly valued Traditional Chinese Medicine, which has been shown to suppress tumor growth and angiogenesis. Total saponins from AJ (TSAJ) are one of the most bioactive components of AJ extract. The present study evaluated the anti‑tumor and anti‑angiogenic effects of TSAJ in vitro and in vivo. The anti‑angiogenic activity of TSAJ was investigat...

2017
Ahmed M. Al-Abd Abdulmohsin J. Alamoudi Ashraf B. Abdel-Naim Thikryat A. Neamatallah Osama M. Ashour

Recent strategies for the treatment of cancer, other than just tumor cell killing have been under intensive development, such as anti-angiogenic therapeutic approach. Angiogenesis inhibition is an important strategy for the treatment of solid tumors, which basically depends on cutting off the blood supply to tumor micro-regions, resulting in pan-hypoxia and pan-necrosis within solid tumor tissu...

Journal: :Experimental eye research 2014
Pierfrancesco Mirabelli Beatrice B Peebo Maria Xeroudaki Marina Koulikovska Neil Lagali

Inflammatory angiogenesis is the pathogenic mechanism of various sight-threatening eye diseases, among them corneal neovascularization. Current treatment options include steroids which have undesirable side effects, or anti-VEGF which has only limited efficacy. In an inflammatory environment, however, angiogenesis can be stimulated by numerous factors not directly targeted by anti-VEGF therapy....

2014
Jin-Mu Yi Jong-Shik Park Jun Lee Jin Tae Hong Ok-Sun Bang No Soo Kim

BACKGROUND Angiogenesis, which is initiated by certain tumor micro-environmental conditions and diverse protein factors, plays a pivotal role during tumor development and metastasis. Therefore, many efforts have been made to develop effective anti-angiogenic agents as anticancer therapeutics. In the current study, we investigated the anti-angiogenic potential of an ethanol extract of Annona ate...

2015
Jennifer Batson Sebastian Oltean David Bates

Pathological angiogenesis occurs when the balance between pro-angiogenic and anti-angiogenic factors is tipped enabling an angiogenic switch. VEGF-A is the primary inducer of angiogenesis but is alternatively spliced at the pre-mRNA level to produce pro-angiogenic and anti-angiogenic isoforms. In previous work we showed that the balance of VEGF-A isoforms is regulated by SRSF1, which is regulat...

2013
Sudarshan Anand

Development of the vasculature is a complex, dynamic process orchestrated by a balance of pro and anti-angiogenic signaling pathways. The same signaling pathways are mis-regulated and exploited during pathological angiogenesis in cancer, inflammation and cardiovascular diseases and contribute to disease progression. In the last decade, small non-coding RNA molecules termed microRNAs (miRs) have...

Journal: :British journal of pharmacology 2012
G M Palmer Z Tiran Z Zhou M E Capozzi W Park C Coletta A Pyriochou Y Kliger O Levy I Borukhov M W Dewhirst G Rotman J S Penn A Papapetropoulos

BACKGROUND AND PURPOSE Pathological angiogenesis is associated with various human diseases, such as cancer, autoimmune diseases and retinopathy. The angiopoietin (Ang)-Tie2 system plays critical roles in several steps of angiogenic remodelling. Here, we have investigated the anti-angiogenic effect of a novel angiopoietin-derived peptide. EXPERIMENTAL APPROACH Using computational methods, we i...

2006
Yelena Mirochnik

Mirochnik Y, Filleur S, Volpert O. Pigment Epithelial derived factor: development of anti-angiogenic peptides. 2006. European J Cancer 4S (12):37 Presentation: Symposium on “Molecular Targets and Cancer Therapeutics”. Prague, Czech Republic 7-10 November 2006 Abstract: Mirochnik Y, Aurora A., Volpert O. Pigment epithelial derived factor: design and development of anti-angiogenic peptides for th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید